ArticleThe Journal of pharmacology and experimental therapeutics2017

Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H).

James Boslett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.